Karl Beutner
Fundador en DermBiont, Inc. .
Cargos activos de Karl Beutner
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
University of California, Berkeley | Corporate Officer/Principal | - | - |
Solano Clinical Research | Fundador | 13/09/2010 | - |
DermBiont, Inc.
DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | Director/Miembro de la Junta | 01/01/2017 | - |
Director Ejecutivo | 01/01/2017 | - | |
Fundador | 01/01/2017 | - | |
Presidente | 01/01/2017 | - | |
Director Técnico/Científico/I+D | 01/01/2017 | - |
Historial de carrera de Karl Beutner
Antiguos cargos conocidos de Karl Beutner.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Director Técnico/Científico/I+D | 01/01/2005 | 01/01/2005 |
Oclassen Pharmaceuticals, Inc.
Oclassen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets. | Director Técnico/Científico/I+D | - | - |
ANACOR PHARMACEUTICALS INC | Director Técnico/Científico/I+D | 25/04/2005 | - |
Formación de Karl Beutner.
St. Mary's College of California | Undergraduate Degree |
State University of New York at Buffalo | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Operativa
Chief Tech/Sci/R&D Officer | 4 |
Founder | 2 |
Undergraduate Degree | 1 |
Sectorial
Consumer Services | 4 |
Health Technology | 3 |
Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Oclassen Pharmaceuticals, Inc.
Oclassen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets. | Health Technology |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Distribution Services |
Solano Clinical Research | |
DermBiont, Inc.
DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Karl Beutner
- Experiencia